VYNE Therapeutics, Inc. (VYNE)
0.3747
0.00 (0.00%)
USD |
NASDAQ |
Dec 09, 13:45
VYNE Therapeutics Market Cap: 12.47M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Theravance Biopharma, Inc. | 911.60M |
| NovaBay Pharmaceuticals, Inc. | 201.62M |
| Palatin Technologies, Inc. | 22.53M |
| Theriva Biologics, Inc. | 7.295M |
| Oragenics, Inc. | 0.7818M |
Market Cap Related Metrics
| PS Ratio | 30.54 |
| Price to Book Value | 0.3887 |
| Price | 0.3747 |
| Earnings Yield | -210.5% |